Initial survival data of kidney transplant patients with pre-transplant monoclonal gammopathy
Monoclonal Gammopathy of Undetermined Significance
In this group, transplantation did not confer a survival benefit. It is our hope that these initial data will serve as a platform for future studies. We suggest MGUS screening in all patients older than 50 yr of age undergoing evaluation for transplantation.